Material Agreement Form 8 K

Item 1.01. Entry into a material definitive agreement

On September 22, 2024, America Great Health (the "Company") entered into a Framework Agreement for Product Project Cooperation (the "Contract") with Xinjiang Wuse Guoshan Supply Chain Management, Co. Ltd., a Chinese company ("Xinjiang Wuse"). The Company's products are a series of ion peptide products developed using "protein surface ion modification technology," achieving a world-leading position in both research and production. Xinjiang Wuse, with its strategic location in Xinjiang, China, has the advantageous resources based on the homology of medicine and food in Xinjiang, and has built a supply chain operation platform for medicine and food from the same source of supply base, product selection center, distribution center and urban warehouse.

Under the Contract, the high-end biotechnology products developed and produced by the Company are consistent with Xinjiang Wuse's product system and will be implanted into its marketing network system as high-end products in the city warehouse. The Company guarantees that its products have relevant compliance qualifications to enter the Chinese market. Xinjiang Wuse designs and distributes marketing channel plans suitable for the Company's products based on the needs of each city's warehouse area.